Showing results (1241-1250 of 1,498) with videos related to

Sort By:
Pageof 150
JACC. Heart Failure|November 30, 2019
Influence of Age on Efficacy and Safety of Spironolactone in Heart FailureOrly Vardeny, Brian Claggett, Muthiah Vaduganathan, et al.
Circulation. Heart Failure|December 21, 2018
Cardiac Troponin I and Risk of Cardiac Events in Patients With Heart Failure and Preserved Ejection FractionPeder L Myhre, Eileen O'Meara, Brian L Claggett, et al.
The New England Journal of Medicine|March 12, 2013
Treatment of anemia with darbepoetin alfa in systolic heart failureKarl Swedberg, James B Young, Inder S Anand, et al.
European Journal of Heart Failure|March 2, 2026
Heart rate and atrial fibrillation/flutter in HFmrEF/HFpEF: a participant-level analysis across five randomized clinical trialsAlberto Foà, Henri Lu, Muthiah Vaduganathan, et al.
Pain|March 16, 2011
Long-term effects of routine morphine infusion in mechanically ventilated neonates on children's functioning: five-year follow-up of a randomized controlled trialJoke de Graaf, Richard A van Lingen, Sinno H P Simons, et al.
PLOS Global Public Health|August 1, 2024
COVID-19 vaccine effectiveness among South Asians in CanadaRahul Chanchlani, Baiju R Shah, Shrikant I Bangdiwala, et al.
JAMA Cardiology|August 25, 2018
Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical TrialPeder Langeland Myhre, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation|June 27, 2023
Clinical Characteristics and Outcomes in Patients With Heart Failure: Are There Thresholds and Inflection Points in Left Ventricular Ejection Fraction and Thresholds Justifying a Clinical Classification?Toru Kondo, Pooja Dewan, Inder S Anand, et al.
Multiple Sclerosis and Related Disorders|June 3, 2025
Approach to JCV testing with natalizumab biosimilar: a UK consensus statementRuth Dobson, Tarunya Arun, James Varley, et al.
Circulation|February 11, 2009
Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trialInder S Anand, Peter Carson, Elizabeth Galle, et al.
Pageof 150